These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 20380632)

  • 1. Recent researches in metal supramolecular complexes as anticancer agents.
    Zhou CH; Zhang YY; Yan CY; Wan K; Gan LL; Shi Y
    Anticancer Agents Med Chem; 2010 Jun; 10(5):371-95. PubMed ID: 20380632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Researches in Metal Supramolecular Complexes as Anticancer Agents.
    Zhou CH; Zhang YY; Yan CY; Wan K; Gan LL; Shi Y
    Anticancer Agents Med Chem; 2010 Apr; ():. PubMed ID: 20380631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper, gold and silver compounds as potential new anti-tumor metallodrugs.
    Tan SJ; Yan YK; Lee PP; Lim KH
    Future Med Chem; 2010 Oct; 2(10):1591-608. PubMed ID: 21426151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine proteases as targets for metal-based drugs.
    Fricker SP
    Metallomics; 2010 Jun; 2(6):366-77. PubMed ID: 21072382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in ruthenium anticancer drugs.
    Levina A; Mitra A; Lay PA
    Metallomics; 2009 Nov; 1(6):458-70. PubMed ID: 21305154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential photoactivated metallopharmaceuticals: from active molecules to supported drugs.
    Crespy D; Landfester K; Schubert US; Schiller A
    Chem Commun (Camb); 2010 Sep; 46(36):6651-62. PubMed ID: 20717579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive luminescent transition-metal complexes for biomedical applications.
    Ma DL; He HZ; Leung KH; Chan DS; Leung CH
    Angew Chem Int Ed Engl; 2013 Jul; 52(30):7666-82. PubMed ID: 23765907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Midas touch in cancer chemotherapy: from platinum- to gold-dithiocarbamato complexes.
    Ronconi L; Fregona D
    Dalton Trans; 2009 Dec; (48):10670-80. PubMed ID: 20023894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy.
    Zhang X; Liu D; Lv F; Yu B; Shen Y; Cong H
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110373. PubMed ID: 31376689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.
    Patil SA; Patil SA; Patil R; Keri RS; Budagumpi S; Balakrishna GR; Tacke M
    Future Med Chem; 2015; 7(10):1305-33. PubMed ID: 26144266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The status of platinum anticancer drugs in the clinic and in clinical trials.
    Wheate NJ; Walker S; Craig GE; Oun R
    Dalton Trans; 2010 Sep; 39(35):8113-27. PubMed ID: 20593091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of metal complexes with G-quadruplex DNA.
    Georgiades SN; Abd Karim NH; Suntharalingam K; Vilar R
    Angew Chem Int Ed Engl; 2010 Jun; 49(24):4020-34. PubMed ID: 20503216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspective: the potential of pyrazole-based compounds in medicine.
    Keter FK; Darkwa J
    Biometals; 2012 Feb; 25(1):9-21. PubMed ID: 22002344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal-based anticancer chemotherapeutic agents.
    Muhammad N; Guo Z
    Curr Opin Chem Biol; 2014 Apr; 19():144-53. PubMed ID: 24608084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in metal-carbene complexes as potent anti-cancer agents.
    Gautier A; Cisnetti F
    Metallomics; 2012 Jan; 4(1):23-32. PubMed ID: 22027962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.